Memory Enhancement in Aging With Optimal Dosing
NCT: NCT07461584 · RECRUITING
Brief Summary
This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Frequently Asked Questions
What is Memory Enhancement in Aging With Optimal Dosing?
Memory Enhancement in Aging With Optimal Dosing is a clinical trial registered under NCT07461584. Current status: RECRUITING.
What is the status of NCT07461584?
The current status of NCT07461584 (Memory Enhancement in Aging With Optimal Dosing) is: RECRUITING.
When did Memory Enhancement in Aging With Optimal Dosing start?
Memory Enhancement in Aging With Optimal Dosing started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.